preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
Published 8 years ago • 356 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:30
final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:25
preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
-
1:35
long-term ibrutinib outcomes vs. prior regimens: pooled analysis in r/r mcl
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
1:09
assessing cardiovascular tolerability of zanubrutinib vs ibrutinib in pts with b-cell malignancies
-
2:04
preliminary results from the blin01 trial
-
2:37
the changing role of autosct in mantle cell lymphoma: the impact of novel agents
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
6:53
laboratory assessment of immune functioning | doctors avigan and ludwig | ims 2023
-
57:37
integrating hematology and coagulation results to enhance diagnosis
-
1:18
estimating long-term outcomes in patients with chl using an oncology simulation model
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
3:50
mantle cell lymphoma advances (part 1)
-
2:41
rb/rc induction for mantle cell lymphoma: promising pooled analysis data
-
1:15
clinical impact of atm and tp53 mutations in mantle cell lymphoma
-
1:03
ecog-e1910 study: clinical benefit of early blinatumomab incorporation in all
-
1:43
ucart22 in b-all: preliminary results from the balli-01 trial
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes
-
1:44
treating mantle cell lymphoma: past approaches and future perspectives
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
2:09
recent investigational advances in mantle cell lymphoma treatment